Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway
Pathogens · 2026
DOI: 10.3390/pathogens15020178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Khalid Al-Shibli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nordlandssykehuset HF, 8092 Bodø, Norway. Hauptthemen laut MEDLINE: Papillomavirus Infections, RNA, Messenger, Oncogene Proteins, Viral, Uterine Cervical Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
HPV DNA–positive women with ASC-US/LSIL cytology represent a heterogeneous risk group in cervical screening and require efficient triage. We evaluated a genotype-specific 7-type HPV E6/E7 mRNA assay (PreTect HPV-Proofer 7; types 16/18/31/33/45/52/58) in a real-world quality-assurance cohort at Nordland Hospital (Bodø, Norway). Among HPV-positive women with ASC-US/LSIL reflex cytology, 225 had sufficient residual liquid-based cytology material and a valid mRNA result; 175 had complete follow-up (2022–2025) and were included. Overall, 44.6% (78/175) were mRNA-positive (ASC-US 45.2%; LSIL 43.3%). For CIN2+, sensitivity was 63.4%, specificity 61.2%, PPV 33.3%, and NPV 84.5%; CIN2+ risk was 33.3% in mRNA-positive versus 15.5% in mRNA-negative women (RR 2.16, 95% CI 1.23–3.78). For CIN3+, risk was 14.1% versus 6.2%. Genotype-specific PPVs were highest for HPV33, HPV18, HPV16, and HPV31. In a referral simulation, mRNA-guided triage reduced baseline colposcopy referrals by 55% and decreased colposcopies per detected CIN2+ by ~30%, while 15 CIN2+ and 6 CIN3+ occurred in the mRNA-negative group and would be expected to be detected at 12-month follow-up among women with persistent HPV positivity. Genotype-aware HPV E6/E7 mRNA triage improves risk stratification and may increase screening efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Nordlandssykehuset HF, 8092 Bodø, Norway.
- Department of Gynecology, Nordlandssykehuset HF, 8092 Bodø, Norway.
- Department of Clinical Pathology, University Hospital of North Norway, 9019 Tromsø, Norway.
ORCID-Profile: Sveinung Wergeland Sørbye
Zitieren
APA
Al-Shibli, K., Nguyen, D. T., Mohammed, H. A. L., & Sørbye, S. W. (2026). Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway. Pathogens. https://doi.org/10.3390/pathogens15020178
Vancouver
Al-Shibli K, Nguyen DT, Mohammed HAL, Sørbye SW. Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway. Pathogens. 2026. doi:10.3390/pathogens15020178
BibTeX
@article{AlShibli2026,
author = {Al-Shibli, Khalid and Nguyen, Dat Tan and Mohammed, Hiba Abdul Latif and Sørbye, Sveinung Wergeland},
title = {Genotype-Specific HPV E6/E7 mRNA Triage Improves Risk Stratification and Reduces Referrals in DNA-Positive ASC-US/LSIL: A Real-World Cohort from Nordland, Norway},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15020178}
}
EUVIMED